Email Updates

You are here

Home»Media

AVAC in the News

  • Thanks for Nothing: iPrEX Volunteers Shut Out of PrEP’s Success

    Most foreign volunteers who participated in the clinical trial that first proved Truvada prevents HIV no longer have access to the drug. Mitchell Warren, executive director of the global HIV advocacy group AVAC, says, “One of the top priorities has got to be—and we’ve raised this over and over again—that Gilead should be applying, at least for registration [of Truvada as PrEP], in each of the countries where any of the PrEP trials took place."

    May 2, 2014
    PrEP
    POZ

  • How Far We've Come In 30 Years Of HIV Research

    David Hyde talks with Mitchell Warren about the breakthroughs and challenges of HIV prevention over the last 30 years. Warren said that one of the greatest breakthroughs in HIV-AIDS prevention was the rise of the citizen activism that pushed for funding, creativity and urgency in research. "AIDS really changed how research happened," he said. "Science changed because communities ‘acted up.’"

    April 29, 2014
    General
    kuow.org

  • Narrow the Gulf Between HIV Prevention Research and Reality

    People around the world have participated in clinical trials that have drastically changed the way we see HIV prevention. This has to be the year where we honor their commitment by following through on our promise to deliver proven options to the communities where they live.

    March 12, 2014
    HIV Vaccine, Cure, Microbicides, PrEP, Voluntary Medical Male Circumcision
    Huffington Post

  • ACT UP protests anti-gay laws at NYC's Ugandan Consulate

    Approximately 50 LGBTI activists protested outside the Ugandan Consulate decrying President Museveni’s passage of three Draconian measures. 

    March 6, 2014
    Edge San Francisco

  • FSN Reports

    AVAC Executive Director Mitchell Warren speaks with Feature Story News about recent developments with long-acting injectables. One injection of anti-retrovirals was shown to protect lab monkeys from HIV for several weeks.

    March 5, 2014
    Feature Story News

  • Injections providing protection against AIDS in monkeys, studies find

    Researchers are reporting that injections of long-lasting AIDS drugs protected monkeys for weeks against infection, a finding that could lead to a major breakthrough in preventing the disease in humans.

    March 4, 2014
    Treatment
    New York Times

  • Crowd-funded HIV vaccine project sparks debate

    A tiny coffee shop table can barely contain Reid Rubsamen, whose restless energy nearly propels him out of his chair as he talks about the Immunity Project, his initiative to crowd-source money to make a new HIV vaccine.

    February 10, 2014
    HIV Vaccine
    Nature

  • The POZ 100: 91 to 100

    The bio of the executive director of AIDS Vaccine Advocacy Coalition (AVAC) says he "uses public education, policy analysis, advocacy and community mobilization to accelerate the ethical development and global delivery of AIDS vaccines and other HIV prevention options" (such as microbicides). We couldn't say it better ourselves. So we didn't try.

    January 7, 2014
    POZ

  • Quicker Action Needed on HIV Prevention

    An AIDS advocacy group says donors and researchers need to work smarter and faster to introduce prevention methods that people will actually use. AVAC says not enough has been done to capitalize on lessons learned from recent studies. AVAC Executive Director Mitchell Warren said that it’s time for a “reality check” in HIV prevention research.

    December 9, 2013
    General
    Voice of America

  • New Achievements on AIDS Show Targets Matter -- So Let's Set New Ones

    As a result of work funded through the President's Emergency Plan for AIDS Relief (PEPFAR), an estimated 1 million children have been born free of HIV and 6.7 million people now receive lifesaving anti-retroviral treatment.

    December 6, 2013
    Voluntary Medical Male Circumcision
    Huffington Post

Pages